Christopher J. Lindop is CFO & EVP Business Development at HAEMONETICS CORP (HAE). They have made 25 open-market trades across 2 companies since 2006, most recently 2020-05-24.
CIK 0001266051
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
13 open-market purchases totalling $188K since 2006, against 12 sales. Across 13 scored buys the stock is down 1.8% at ninety days, and 2.1 points behind the S&P over the same stretch.
13 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 0% | 0% |
| Avg Move | -4.2% | -1.8% | -1.8% |
| Alpha | +1.6% | -2.1% | -2.1% |
| Scored | 13 | 13 | 13 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PRXL | SELL | 2016-03-01 | 2016-03-03 | $60.28 | $121K | -3.2% | +5.7% | +3.7% |
| HAE | SELL | 2015-10-26 | 2015-10-28 | $32.13 | $14K | -4.4% | -2.0% | -1.7% |
| HAE | SELL · 10b5-1 | 2015-08-20 | 2015-08-24 | $38.49 | $189K | -4.4% | -2.0% | -2.0% |
| HAE | SELL · 10b5-1 | 2015-07-20 | 2015-07-21 | $39.09 | $192K | -4.4% | -2.0% | -2.0% |
| HAE | SELL · 10b5-1 | 2015-06-22 | 2015-06-23 | $42.51 | $208K | -4.4% | -2.0% | -2.0% |
| HAE | SELL · 10b5-1 | 2015-05-20 | 2015-05-21 | $41.65 | $204K | -4.4% | -2.0% | -2.0% |
| HAE | SELL · 10b5-1 | 2015-04-20 | 2015-04-22 | $41.55 | $204K | -4.4% | -2.0% | -2.0% |
| HAE | SELL · 10b5-1 | 2015-03-20 | 2015-03-24 | $44.26 | $217K | -4.4% | -2.0% | -2.0% |
| PRXL | SELL | 2015-02-19 | 2015-02-23 | $63.59 | $127K | -3.3% | -0.4% | -0.4% |
| PRXL | SELL | 2014-11-05 | 2014-11-06 | $55.00 | $660K | -3.3% | -0.4% | -0.4% |
| PRXL | SELL | 2014-02-04 | 2014-02-06 | $49.00 | $490K | -3.3% | -0.4% | -0.4% |
| HAE | SELL · 10b5-1 | 2013-06-18 | 2013-06-20 | $42.50 | $2.9M | -4.4% | -2.0% | -2.0% |
| HAE | SELL · 10b5-1 | 2013-05-21 | 2013-05-23 | $42.00 | $1.8M | -4.4% | -2.0% | -2.0% |
| HAE | BUY | 2013-04-30 | 2013-05-02 | $32.73 | $13K | -4.4% | -2.0% | -2.0% |
| PRXL | SELL | 2013-02-12 | 2013-02-13 | $34.40 | $87K | -3.3% | -0.4% | -0.4% |
| HAE | SELL | 2012-11-20 | 2012-11-21 | $80.95 | $23K | -4.4% | -2.0% | -2.0% |
| HAE | BUY | 2012-11-01 | 2012-11-05 | $61.46 | $8K | -4.4% | -2.0% | -2.0% |
| PRXL | SELL · 10b5-1 | 2012-09-25 | 2012-09-26 | $30.92 | $158K | -3.3% | -0.4% | -0.4% |
| PRXL | SELL · 10b5-1 | 2012-09-11 | 2012-09-12 | $30.10 | $235K | -3.3% | -0.4% | -0.4% |
| HAE | SELL · 10b5-1 | 2012-09-04 | 2012-09-06 | $74.34 | $4.6M | -4.4% | -2.0% | -2.0% |
| HAE | BUY | 2012-05-01 | 2012-05-03 | $49.83 | $13K | -4.4% | -2.0% | -2.0% |
| PRXL | SELL | 2012-03-08 | 2012-03-08 | $24.33 | $97K | -3.3% | -0.4% | -0.4% |
| HAE | BUY | 2011-11-03 | 2011-11-07 | $51.81 | $11K | -4.4% | -2.0% | -2.0% |
| PRXL | SELL · 10b5-1 | 2011-09-19 | 2011-09-20 | $20.98 | $52K | -3.3% | -0.4% | -0.4% |
| PRXL | SELL · 10b5-1 | 2011-09-13 | 2011-09-14 | $20.34 | $45K | -3.3% | -0.4% | -0.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.